证券简称：新里程 证券代码：002219 公告编号：2025-049 新里程健康科技集团股份有限公司 关于重大事项的进展公告 特别提示： 本公司及董事会全体成员保证公告内容真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏。 新里程健康科技集团股份有限公司 2025 年 9 月 21 日，公司收到林杨林先生家属的通知，其收到太原市小店区 监察委员会出具的《解除留置通知书》，太原市小店区监察委员会已解除对林杨 林先生的留置措施。目前，林杨林先生已能正常履行公司董事长的职责，公司生 产经营情况正常。许铭桂先生将不再代为履行公司董事长的职责。 公司指定信息披露媒体为《证券日报》《证券时报》《中国证券报》《上海证 券报》和巨潮资讯网，公司发布的信息均以在上述媒体刊登的公告为准。敬请广 大投资者注意投资风险。 特此公告。 新里程健康科技集团股份有限公司 董 事 会 二〇二五年九月二十二日 1 新里程健康科技集团股份有限公司（以下简称"公司"）于 2025 年 7 月 7 日披露《关于重大事项的公告》（公告编号：2025-041），公司董事长林杨林先生 被太原市小店区监察委员会实施留置并立案调查。 ...

Company Overview - New Mile Health Technology Group Co., Ltd. is located in Chaoyang District, Beijing, and was established on September 30, 2001. The company was listed on March 6, 2008. Its main business involves the manufacturing of pharmaceuticals (including traditional Chinese medicine) and medical services [1][2]. Financial Performance - For the period from January to June 2025, New Mile reported a revenue of 1.588 billion yuan, a year-on-year decrease of 12.76%. The net profit attributable to the parent company was 7.4311 million yuan, down 87.64% year-on-year [2]. - Since its A-share listing, New Mile has distributed a total of 70.3476 million yuan in dividends, with no dividends paid in the last three years [3]. Stock Performance - As of September 18, New Mile's stock price decreased by 2.01%, trading at 2.44 yuan per share, with a total market capitalization of 8.265 billion yuan. The stock has seen a year-to-date decline of 7.58%, but has increased by 11.42% over the last five trading days [1]. - The stock's trading volume on September 18 was 365 million yuan, with a turnover rate of 4.50% [1]. Shareholder Information - As of August 20, the number of shareholders for New Mile reached 69,300, an increase of 3.21% from the previous period. The average number of circulating shares per person was 47,238, a decrease of 3.11% [2]. - As of June 30, 2025, Hu Long Securities Co., Ltd. was the ninth largest circulating shareholder, holding 60 million shares, unchanged from the previous period [3]. Business Segmentation - The company's revenue composition is primarily from medical services (86.79%), followed by pharmaceuticals and medical products (13.12%), with other sources contributing 0.09% [1].

Market Overview - On September 17, the medical services sector rose by 0.02% compared to the previous trading day, with Yinos leading the gains [1] - The Shanghai Composite Index closed at 3876.34, up 0.37%, while the Shenzhen Component Index closed at 13215.46, up 1.16% [1] Top Gainers in Medical Services Sector - Yinos (688710) closed at 46.85, with an increase of 8.65% and a trading volume of 46,200 lots, amounting to a transaction value of 207 million [1] - New Mileage (002219) closed at 2.49, up 4.18%, with a trading volume of 2,568,500 lots and a transaction value of 638 million [1] - Prasis (301257) closed at 50.33, increasing by 3.52% with a trading volume of 50,700 lots, totaling 249 million [1] Top Losers in Medical Services Sector - Medisi (688202) closed at 76.00, down 5.41%, with a trading volume of 91,400 lots and a transaction value of 700 million [2] - Yaoshi Technology (300725) closed at 44.74, decreasing by 5.11%, with a trading volume of 262,900 lots and a transaction value of 1.18 billion [2] - Zhaoyan New Drug (603127) closed at 40.40, down 4.27%, with a trading volume of 444,300 lots and a transaction value of 1.806 billion [2] Fund Flow Analysis - On the same day, the medical services sector experienced a net outflow of 626 million from institutional investors, while retail investors saw a net inflow of 482 million [2] - The top stocks by net inflow from institutional investors included Yinos (688710) with a net inflow of 26.06 million, and New Mileage (002219) with 38.30 million [3] - Conversely, the top stocks with net outflow from institutional investors included Yao Ming Kande (603259) with a net outflow of 428 million [3]

Core Insights - The medical services sector experienced a slight increase of 0.29% on September 16, with Chengda Pharmaceutical leading the gains [1] - The Shanghai Composite Index closed at 3861.87, up 0.04%, while the Shenzhen Component Index closed at 13063.97, up 0.45% [1] Medical Services Sector Performance - Chengda Pharmaceutical (301201) closed at 33.32, with a significant increase of 15.25% and a trading volume of 157,100 shares, amounting to a transaction value of 508 million yuan [1] - Haocen Medical (002622) saw a rise of 10.10%, closing at 4.25 with a trading volume of 993,200 shares, totaling 409 million yuan [1] - Aoyang Health (002172) increased by 10.00%, closing at 4.73 with a trading volume of 87,500 shares, amounting to 41.39 million yuan [1] - Bid Pharma (688073) rose by 6.48%, closing at 74.73 with a trading volume of 26,000 shares, totaling 192 million yuan [1] - Yikang Biological (688046) increased by 5.56%, closing at 19.75 with a trading volume of 79,600 shares, amounting to 158 million yuan [1] - Other notable performers include Haoyuan Pharmaceutical (688131) with a 4.44% increase, closing at 78.28, and Xinlicheng (002219) with a 3.46% increase, closing at 2.39 [1] Fund Flow Analysis - The medical services sector saw a net outflow of 228 million yuan from institutional investors, while retail investors contributed a net inflow of 59.64 million yuan [3] - Speculative funds recorded a net inflow of 168 million yuan into the sector [3]

Group 1 - The establishment of the Turkey-China (Beijing Changping) Trade Center marks a significant achievement in international investment attraction for the Changping District, serving as a new milestone for deepening international cooperation [1][3] - Five leading Turkish companies have settled in the Changping Trade Center, including two Fortune 500 companies: YEO, a listed company in the renewable energy sector, and GES Group, renowned in energy construction [3] - The G20 Young Entrepreneurs Alliance China Headquarters played a crucial role in facilitating this collaboration, leveraging its global network and resource integration capabilities to enhance communication and cooperation between Changping District and international enterprises [3][5] Group 2 - The Turkish Ministry of Trade sent an official congratulatory letter, emphasizing that the establishment of the Trade Center is a valuable practice to strengthen bilateral cooperation between Turkey and China [5] - The initiative is expected to deepen exchanges and connections between young entrepreneurs from both countries, injecting new vitality into mutual prosperity [5] - Changping has attracted several multinational corporate regional headquarters through its "Two Zones" construction policy, establishing high-end innovation platforms such as the Zhongguancun National Laboratory and Beijing Life Science Research Institute [5]

Group 1 - Alphabet's market capitalization reached $3 trillion for the first time, making it the fourth largest company in the U.S. stock market, following Nvidia, Microsoft, and Apple [1] - The stock price of Alphabet increased by 4.3% to $251.76, with a year-to-date increase of over 33%, outperforming the S&P 500 index's 12.5% gain [1] - A recent court ruling allowed Alphabet to maintain control over its Chrome browser and Android operating system, alleviating investor concerns about potential divestitures [2] Group 2 - Alphabet's cloud computing revenue grew nearly 32% year-over-year in Q2, exceeding market expectations, driven by investments in self-developed chips and the Gemini AI model [2] - The company is diversifying beyond its core search business, with developments in YouTube, Waymo, and other products, indicating a shift towards a more varied business model [2] - Alphabet's current expected price-to-earnings ratio is approximately 23, slightly above its five-year average of 22, but lower than other companies in the "Magnificent 7" [2]

Core Viewpoint - The company, New Mileage Health Technology Group Co., Ltd., has announced a postponement of the election for its sixth board of directors and supervisory board, which is set to expire on September 13, 2025, to ensure continuity and stability in governance [2]. Group 1 - The sixth board of directors and supervisory board's term will be extended until the election process is completed [2]. - All members of the sixth board of directors, supervisory board, and their respective committees will continue to fulfill their duties and obligations as per relevant laws and the company's articles of association [2]. - The postponement of the board elections will not affect the normal operations of the company, which will actively promote the election process and fulfill its information disclosure obligations in a timely manner [2].

新里程健康科技集团股份有限公司 特此公告。 新里程健康科技集团股份有限公司 董 事 会 新里程健康科技集团股份有限公司 关于董事会、监事会延期换届选举的公告 特别提示： 本公司及董事会全体成员保证公告内容真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏。 新里程健康科技集团股份有限公司（以下简称"新里程"或"公司"）第六 届董事会、监事会任期将于 2025 年 9 月 13 日届满。鉴于公司换届选举的相关工 作尚在筹备中，为保证公司董事会、监事会工作的连续性和稳定性，公司第六届 董事会、监事会将延期换届，公司第六届董事会各专门委员会、高级管理人员的 任期也将相应顺延。在换届选举工作完成前，公司第六届董事会和监事会全体成 员、董事会各专门委员会成员及高级管理人员将按照相关法律、法规和《公司章 程》的相关规定，继续履行相应的职责和义务。 本次公司董事会、监事会延期换届不会影响公司的正常运营。公司将积极推 进相关换届选举工作，并及时履行信息披露义务。 证券简称：新里程 证券代码：002219 公告编号：2025-048 二〇二五年九月十二日 1 ...

Core Insights - Lenovo Group's Wuhan manufacturing base has achieved a significant milestone with the successful rollout of its 300 millionth smart terminal, specifically the latest foldable device, the Lenovo Moto Razr 60 Pro [1][5] - The Wuhan base has transformed from a single-function manufacturing facility into Lenovo's largest and most advanced mobile smart terminal R&D and manufacturing hub, producing smartphones and tablets for over 160 countries and regions since its inception in 2013 [2][5] Group 1 - The successful launch of the 300 millionth device showcases Lenovo's strength in smart manufacturing, which aligns with the rapid growth of its mobile business in the global market [5] - In the global foldable smartphone market, Lenovo's Moto Razr series has shown strong performance, with a 45% year-on-year increase in shipments in the second quarter, and its market share doubling from 14% to 28% [5] - Lenovo's Wuhan base has been a key driver of regional economic development, being the largest foreign trade enterprise in Hubei province for ten consecutive years, with cumulative exports exceeding $50 billion [5] Group 2 - Lenovo actively plays a "chain master" role, fostering collaboration with local suppliers and partners to build a robust industrial ecosystem, including partnerships with Wuhan Tianma and Huaxing Optoelectronics [6] - The Wuhan base is leveraging intelligent manufacturing technologies to drive industrial transformation, utilizing AI systems to optimize production planning and material requirements [6] - The development of the second generation of intelligent systems is underway, with expectations to complete by the end of the year, followed by further advancements in subsequent generations [6]

Core Viewpoint - The acquisition of Qinhuai Data China by Dongyangguang and its controlling shareholder marks the largest merger and acquisition transaction in China's data center industry to date, valued at 28 billion yuan [1][2]. Group 1: Acquisition Details - Dongyangguang and Shenzhen Dongyangguang Industrial Development Co., Ltd. plan to jointly increase capital in Yichang Dongshu No.1 Investment Co., Ltd. with amounts of 3.5 billion yuan and 4 billion yuan respectively [2]. - The acquisition will be executed through Dongshu No.3, a wholly-owned subsidiary of Dongshu No.1, which will acquire 100% of Qinhuai Data China's business operations [2]. - Following the transaction, Dongyangguang will become a shareholder of Dongshu No.1 and indirectly hold shares in Qinhuai Data China [2]. Group 2: Strategic Importance - The chairman of Shenzhen Dongyangguang emphasized that this acquisition is a key step for the group to integrate into the national "East Data West Computing" strategy and to support the construction of a unified national computing network [3]. - The acquisition aims to ensure business continuity and stability while leveraging both companies' resources in liquid cooling materials, AIDC, and clean energy [3]. Group 3: Financial Projections - Qinhuai Data China is projected to generate revenues of 6.048 billion yuan and a net profit of 1.309 billion yuan in 2024, with revenues of 2.608 billion yuan and a net profit of 745 million yuan in the first five months of 2025 [3][4]. Group 4: Synergy and Collaboration - The collaboration will focus on four dimensions: regional layout, technology, product, and demand [3]. - Dongyangguang will provide low-cost green electricity and expansion bases for Qinhuai Data China, leveraging clean energy reserves in various regions [3]. - The integration of Dongyangguang's liquid cooling technology with Qinhuai Data China's operations aims to create an efficient full-stack solution for the industry [4]. - The demand for computing power from Dongyangguang's intelligent robotics business is expected to grow exponentially, with Qinhuai Data China providing customized data center services to meet these needs [4].